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Background: Prenatal exposure to persistent organic pollutants (POPs), may influence offspring weight gain. More
prospective epidemiological studies are needed to compliment the growing body of evidence from animal studies.
Methods: Serum from 412 pregnant Norwegian and Swedish women participating in a Scandinavian prospective
cohort study were collected in 1986–88, and analyses of two perfluoroalkyl substances (PFASs) and five organochlorines
(OCs) were conducted. We used linear and logistic regression models with 95% confidence intervals (CIs) to evaluate the
associations between maternal serum POP concentrations at 17–20 weeks of gestation and child overweight/obesity
(body mass index (BMI) ≥ 85th percentile) at 5-year follow-up. Results were further stratified by country after testing for
effect modification. We also assessed potential non-monotonic dose-response (NMDR) relationships.
Results: In adjusted linear models, we observed increased BMI-for-age-and-sex z-score (β= 0.18, 95% CI: 0.01–0.35), and
increased triceps skinfold z-score (β= 0.15, 95% CI: 0.02–0.27) in children at 5-year follow-up per ln-unit increase in maternal
serum perfluorooctane sulfonate (PFOS) concentrations. We observed increased odds for child overweight/obesity (BMI≥
85th percentile) for each ln-unit increase in maternal serum PFOS levels (adjusted OR: 2.04, 95% CI: 1.11–3.74), with stronger
odds among Norwegian children (OR: 2.96, 95% CI: 1.42–6.15). We found similar associations between maternal serum
perfluorooctanoate (PFOA) concentrations and child overweight/obesity. We found indications of NMDR relationships
between PFOS and polychlorinated biphenyl (PCB) 153 and child overweight/obesity among Swedish children.
Conclusion: We found positive associations between maternal serum PFAS concentrations and child overweight/obesity
at 5-year follow-up, particularly among Norwegian participants. We observed some evidence for NMDR relationships
among Swedish participants.
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The prevalence of childhood overweight and obesity
(BMI ≥ 85th percentile) has increased dramatically over
the past decades [1]. From 1990 to 2010, the global esti-
mated prevalence of overweight and obesity among pre-
school children increased from 4.2% to 6.7% [1]. This
trend is expected to continue, and the World Health
Organization (WHO) predicts that 60 million preschool
children worldwide (9.1%) will be overweight or obese by
2020 [1]. Childhood obesity is a risk factor for several
chronic diseases later in life including diabetes, cardiovas-
cular disease, musculoskeletal disorders, and some forms
of cancer [2]. Dietary influences, a sedentary lifestyle, as
well as possible gene-environment interactions are import-
ant determinants of the increasing obesity trends, but they
do not completely account for the obesity epidemic [3].
An increasing body of evidence suggests that in utero
exposure to endocrine disrupting chemicals (EDCs) may
contribute to obesity development in children and adults
[3, 4]. Animal and in vitro studies suggest that EDCs may
cause obesity through interference with lipid metabolism
to promote fat storage, by altering the metabolic set points,
or modifying hormonal control of appetite and satiety [4].
Obesity may be programmed in the intrauterine period,
and fetal exposure to certain EDCs may modify the epige-
nome of stem cells to preferentially produce more adipo-
cytes at the cost of bone [5].
Several persistent organic pollutants (POPs), including
perfluoroalkyl substances (PFASs) and organochlorines
(OCs), are classified as EDCs [4]. PFASs and OCs are
ubiquitous, persistent and bio-accumulative chemicals
that have been detected in maternal serum throughout
pregnancy and in cord blood at delivery. Although the
use of some POPs is presently banned or restricted in
many countries [6], adverse health outcomes related to
background levels of POP exposures are still a major
public health concern [7].
Compared to animal studies, prospective epidemio-
logical studies investigating the association between ma-
ternal serum POP concentrations during pregnancy and
offspring postnatal obesity are less extensive [8, 9]. For
PFAS exposures, longitudinal studies have reported both
positive [10–15] and no associations [16, 17]. For OCs,
prenatal exposure to p,p’-dichlorodiphenyldichloroethane
(p,p’-DDE) has been associated with increased body mass
index (BMI) in infancy and childhood [8, 9], but less
consistent findings are reported for associations with
prenatal polychlorinated biphenyl (PCB) and hexachloro-
benzene (HCB) [8, 9]. Most previous studies used
anthropometric indices, such as BMI, as proxies for off-
spring body composition [18]. However, children with the
same amount of body fat can have quite different BMI
values. For this reason, skinfold thickness may be a more
informative measure of body fat mass in children [19].The current study includes 412 mother-child pairs from
a Scandinavian prospective cohort study with participants
from Norway and Sweden. We aimed to evaluate the asso-
ciations between maternal serum POP concentrations in
early pregnancy and offspring anthropometry, including
child overweight/obesity at 5-year follow-up.
Methods
Study participants
This current study uses data from the U.S. National Insti-
tute of Child Health and Human Development (NICHD)
Scandinavian Successive Small-for-Gestational Age births
study (The SGA Study) [20]. The SGA Study is a large
multi-center prospective cohort study conducted in
Trondheim and Bergen (Norway) and Uppsala (Sweden)
from 1986 to 1988. The SGA Study was designed to study
longitudinal fetal growth, as well as perinatal and postna-
tal outcomes among mother and child [20]. In brief, all
pregnant women (< 20 weeks gestation) in the study
catchment areas who were expecting their 2nd or 3rd
child were eligible for study inclusion and made the first
appointment (n = 5722) (Fig. 1). Women with elevated risk
for an SGA birth were intentionally oversampled. Risk
factors for SGA birth included a previous low birth weight
child, previous perinatal death, low maternal pre-
pregnancy weight (< 50 kg), maternal smoking at concep-
tion and/or chronic maternal hypertension or renal
disease. All high-risk pregnancies resulting in an SGA
birth (birth weight below 10th percentile adjusted for sex
and parity), and a 10% random sample of the study popu-
lation were invited for follow-up when children were five
years of age (n = 791). Of these, 534 (68%) attended the 5-
year evaluation. In the current study, 412 mother-child
pairs (137 SGA births and 275 non-SGA births) were
included in the analyses (Fig.1).
Exposure assessment of maternal serum POP
concentrations
According to study protocol (1986–88), maternal serum
samples were collected in the 2nd trimester (gestational
week 17–20) and stored at minus 80 °C for later analysis.
Analyses of maternal serum PFAS and OC concentra-
tions were performed.
PFAS analyses
The PFAS analyses were performed at the laboratories of
Norwegian Institute for Air Research, Tromsø, Norway
(NILU). Maternal serum samples were quantified for two
target analytes including perfluorooctanoate (PFOA) and
perfluorooctane sulfonate (PFOS). Detailed information
about the sample preparation, extraction method, analyt-
ical method, reagents and instrumentation is previously
reported [21, 22]. Maternal serum PFAS concentrations
were determined using sonication-facilitated liquid-liquid
Women recruited to the study (n=6,354)
Excluded:
• Ineligible (n=432)
• Did not make first appointment 
(n=200)







Did not attend five- year follow-up (n=253) 
Non-SGA births (n=1,154)
Eligible for follow-up after birth (n=791)
Norway: 385 (149 SGA and 236 non-SGA)
Sweden: 406 (142 SGA and 264 non-SGA)
Included participants (n=412)
Norway: 254 (85 SGA and 169 non-SGA)
Sweden: 158 (52 SGA and 106 non-SGA)
Five-year follow-up (n=538)
Norway: 318 (104 SGA and 214 non-SGA)
Sweden: 220 (80 SGA and 140 non-SGA)
No anthropometric measurements at five-
year follow-up (n=12)
Lack of serum samples (n=110)
Fig. 1 Flow chart of participants
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analyzed by ultrahigh pressure liquid chromatography
triple-quadruple mass-spectrometry (UHPLC-MS/MS).
Participation in the AMAP Ring Test [24] ensures that the
uncertainties of the analysis are within ±15–20% of the
assigned values.
OC analyses
Maternal serum OC concentrations were analysed at the
Institut National de Santé Publique du Quebec, Centre
Toxicologie, Quebec. Several OCs were measured, in-
cluding hexachlorobenzene (HCB), oxychlordane, poly-
chlorinated biphenyl (PCB) 52, 101, 118, 153, 156, 170,
and 180, p,p’-dichlorodiphenyldichloroehylene (p,p’-
DDE), p,p’-dichlorophenyltrichloroethane (p,p’-DDT), β-
hexachlorohexane (β-HCH) and trans-nonachlor (t-NC).
In short, 0.5–1 ml serum sample was extracted using
hexane (2 × 6 ml), ethanol (2 ml) and saturated ammo-
nium sulphate solution (2 ml). This method is a slight
modification of the one described by Sandanger et al.
[25], where the samples were cleaned up using 1 g of ac-
tivated fluorisil on an automated Liquid handler system
before GC-MS analysis [26]. Uncertainties of the analysesare within ±15–20% of the assigned values, which are
confirmed by participation in the AMAP Ring Test [24].
Lipids were enzymatically determined and the summed
lipid amounts were calculated based on triglycerides and
cholesterol measurements using the following formula:
Total lipids = 1.33*triglycerides +1.12*cholesterol +1.48
(g/l) [27]. This formula showed good correlation with
complete formulas including phospholipids [28].
We report PCB 153 as a proxy for total PCBs, and
excluded p,p-DDT because of low limit of detection
(LOD) (> 50% of samples < LOD). LODs are listed in
Table 2. Values below LOD were replaced by LOD/√2.
Outcome assessment of child overweight/obesity
Child weight was recorded at 5-year follow-up in the
clinic by trained professionals using a standard proced-
ure. Standing weight was recorded to the nearest 100 g.
Standing height was measured according to standard
procedures and recorded to the nearest 0.1 cm [29].
BMI was calculated from weight in kilograms (kg)
divided by height in meters squared (kg/m2). We used
offspring age (in months), offspring sex and offspring
BMI to calculate age-and-sex-specific BMI z-scores. BMI
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standards for children 5 years or younger [30], and the
2007 WHO growth standards for children and adolescents
aged 5 to 19 years [18]. We assessed child age-and-sex-spe-
cific BMI z-scores as a continuous outcome at 5-year
follow-up. We also analyzed child overweight/obesity at 5-
year follow-up categorically (BMI ≥ 85th percentile for age
and sex compared to BMI below the 85th percentile) [31].
Skinfold thickness was measured once using a Harpenden
caliper (John Bull, British Indicators Ltd.) to the nearest
0.10 mm and 60 s after release of the grip to allow full
tension placed on the compressed skinfold. Subscapular
skinfold thickness was measured below the inferior angle
of the left scapula, and triceps skinfold thickness was mea-
sured over the triceps in the middle of the left upper arm
[29, 32]. We calculated age-and-sex-specific z-scores for
triceps and subscapular skinfolds according to the Center
for Disease Control and Prevention (CDC) 2000 Growth
Charts for children from 1.5 to 20 years of age [33].
Covariates
Information on maternal age, height, pre-pregnancy
weight, education, smoking habits, previous breastfeed-
ing duration and inter-pregnancy interval were collected
via in-person interviews and self-report questionnaires
during the original study period as per SGA Study
protocol. Maternal pre-pregnancy BMI was calculated
based on self-reported height and weight at first study
visit. We calculated maternal weight gain up to 17 weeks
of gestation as the difference between self-reported pre-
pregnancy weight and clinically recorded weight closest
to gestational week 17 (done by the woman’s own mid-
wife or GP). Based on a known J-shaped association with
adverse perinatal outcomes including restricted fetal
growth [34], we categorized the inter-pregnancy interval
as <18 months, 19–60 months and > 60 months since
their last birth.
Statistical analyses
Maternal serum PFAS and OC concentrations were
logarithmically (ln) transformed to obtain normal distri-
bution. We used wet weight maternal serum PFAS
concentrations, and lipid-adjusted maternal serum OC
concentrations [27].
We used multivariable linear regression with 95%
confidence intervals (CIs) to examine the association
between ln-transformed maternal serum concentrations
of seven separate POPs (PFASs: PFOA, PFOS; OCs:
PCB153, p,p’-DDE, HCB, t-NC and β-HCH) and off-
spring i) sex-and-age-specific z-scores for BMI at 5-year
follow-up, and ii) sex-and-age-specific triceps and
subscapular skinfolds at 5-year follow-up. We used mul-
tivariable logistic regression to estimate adjusted odds
ratios (ORs) and 95% CIs for the association betweenmaternal serum POP concentrations and child over-
weight/obesity (BMI z-scores ≥ 85th percentile for age and
sex) at 5-year follow-up. We constructed a directed acyclic
graph (DAG) to assess and select potential confounders
(Additional file 1: Fig. S1). Prenatal growth was considered
a mediator in the pathway between exposure to POPs and
childhood overweight, due to positive associations
between increasing prenatal levels and POPs and SGA
birth in our study sample [35]. As adjustment for a medi-
ator may introduce collider bias if there are shared un-
measured causes of both the mediator (SGA status) and
the outcome (childhood overweight) [36], we did not in-
clude prenatal growth or SGA status in the multivariate
analyses. The following variables were included in multi-
variable analyses as potential confounders: maternal age
(continuous; years), maternal pre-pregnancy body mass
index (BMI) (continuous: kg/m2), maternal education (cat-
egorical: < 9 years, 10–12 years, or ≥ 13 years), maternal
smoking status at conception (categorical: 0, 1–9 or ≥ 10
cigarettes per day), previous breastfeeding duration (con-
tinuous: months), inter-pregnancy interval between the
last two children (categorical: ≤ 18 months, 19–60 months,
≥ 61 months), and maternal weight gain from conception
up to gestational week 17 (continuous: kilograms). The
pooled analyses were further adjusted by country (Norway
or Sweden). All models were tested for normality of resid-
uals, heteroscedasticity, and multi-collinearity.
We examined linearity by scatter plots, assigning
maternal serum POP concentrations to the horizontal
axis, and measures of child adiposity to the vertical axis.
Marginal relationships between maternal serum POP
concentrations and offspring BMI z-scores at 5-year
follow-up were assessed by non-linear regression using
3-knot restricted cubic splines and 95% CIs. We deter-
mined non-linear associations by examination of cubic
spline graphs, and by the Wald test.
We had some missing data including 7.2% missing for
both maternal weight gain up to gestational week 17 and
previous breastfeeding duration. Among children, we
had 7.0% missing data on subscapular skinfold thickness
and 6.1% missing data on triceps skinfold thickness.
Overall, 80% of participants had complete data on all
variables. Missing data were assumed missing at random.
We used chained multiple imputation [37, 38] to gener-
ate and compare five complete data sets. Complete case
analyses widened the 95% CIs, but did not change the
estimates substantially.
We evaluated possible effect modification by country
and offspring sex based on a priori evidence from the
literature [12, 35]. We conducted several sensitivity ana-
lyses to assess the robustness of our results. First, we did
stratum-weighted analyses to ensure generalizability of
our reported estimates to the contemporary pregnant
population according to the prevalence of i) SGA births,
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smoking at conception (See Additional file 1: Supplementary
description S1 for details). Such weighted analyses are
recommended for analyses with case-control data or in
other way unbalanced populations that may be subject to
selection bias [39]. Second, we additionally adjusted for ma-
ternal fish consumption during pregnancy among Norwe-
gian participants (See Additional file 1: Supplementary
description S2 for details). Finally, we considered a multi-
pollutant model approach by mutually adjusting for mater-
nal serum POPs that were found to be associated with
offspring BMI.
All statistical analyses were conducted with SPSS stat-
istical software, version 22 (IBM SPSS Inc. Chicago, IL)
and Stata IC/13.1.
Results
Overall, mean maternal age at study start was 29 years,
with 69% of women expecting their second child, and
31% expecting their third (Table 1). Mean duration of
previous breastfeeding was 7 months. On average,
mothers gained 3.2 kg from conception up to gestational
week 17. Overall, 10% of mothers were underweight
(BMI < 18.5 kg/m2) at conception, and 9% were over-
weight or obese (BMI ≥ 25 kg/m2), with some variation
between countries. A higher proportion of Norwegian
mothers were underweight (BMI < 18.5 kg/m2) at con-
ception compared to their Swedish peers (12% vs. 7%). A
total of 53% of Norwegian mothers reported smoking at
conception, compared to 33% of the Swedish mothers.
Children at 5-year follow-up were evenly distributed
by sex (51% boys and 49% girls), wherein 1/3 were cate-
gorized as SGA births (reflecting the oversampling of
SGA births for follow-up). Norwegian children had
slightly lower birth weight (3401 vs. 3515 g), and were
breastfed longer (6.8 vs. 6.0 months) than Swedish chil-
dren. Norwegian children were also younger at 5-year
follow-up (Norway: 61 months, Sweden: 65 months). A
total of 55 children (12%) were considered overweight or
obese at 5-year follow-up (Norway: 14%, Sweden: 10%).
In our study population, Norwegian children had higher
sex-and-age-adjusted z-scores of subscapular skinfold
thickness (Norway: 0.18; Sweden: −0.32), and triceps
skinfold thicknesses (Norway: 0.32; Sweden: −0.07) com-
pared to Swedish children (Table 1).
Norwegian mothers had substantially lower median
serum PFOA concentration (1.64 vs. 2.33 ng/ml), PFOS
concentration (9.62 vs. 16.3 ng/ml), PCB 153 concentra-
tion (79.9 vs. 117 ng/g lipid) and β-HCH concentration
(21.2 vs. 25.0 ng/g lipid) compared to Swedish mothers
(Table 2). Norwegian mothers had higher median serum
t-NC concentration (6.77 vs. 6.28 ng/g lipid) compared
to Swedish mothers. Median maternal serum HCB con-
centrations (17.0 vs. 18.4 ng/g lipid) and p,p’-DDEconcentrations (211 vs. 244 ng/g lipid) did not differ
between countries (Table 2).
Adjusted linear and logistic associations between
maternal serum concentrations of PFASs and OCs, and
measures of child adiposity at 5-year follow-up are
shown in Table 3. These results are stratified by country
of residence based on some indication of effect modifica-
tion by country (pinteraction = 0.039) between maternal
serum PFOS concentrations and offspring BMI z-scores
as well as child overweight/obesity at 5-year follow-up
(pinteraction = 0.098). In the total cohort, adjusted BMI-
for-age-and-sex z-score increased by 0.18 (95% CI:
0.01–0.35) and adjusted triceps skinfold z-score
increased by 0.15 (95% CI: 0.02–0.27) for each ln-unit
increase in maternal serum PFOS concentrations. For
each ln-unit increase in maternal serum PFOS concen-
tration, the adjusted OR for child overweight/obesity
was 2.04 (95% CI: 1.11–3.74). The data also suggests
positive associations between maternal serum PFOA
concentrations and child BMI z-scores, triceps skin-
folds z-scores and child overweight/obesity at 5-year
follow-up (Table 3).
Among Norwegian children, we observed increased
BMI-for-age-and-sex z-scores for each ln-unit increase
in maternal serum PFOS concentration (β:0.30 (95% CI:
0.08, 0.51), and each ln-unit increase in maternal serum
PFOA concentration (β:0.32 (95% CI: 0.05, 0.60)
(Table 3). Norwegian children also showed increased tri-
ceps skinfold z-scores per ln-unit increase in maternal
serum PFOS concentration (β:0.20, 95% CI: 0.06, 0.35)
and maternal serum PFOA concentration (β: 0.24, 95%
CI: 0.05, 0.42). BMI z-scores increased by 0.45 (95% CI:
0.03, 0.87) for each ln-unit increase in maternal serum
PCB 153 concentration in the Norwegian part. No asso-
ciations were observed among Swedish participants.
In adjusted logistic regression, we observed no overall
association between maternal serum POP concentrations
and child adiposity or overweight/obesity in the pooled
analyses. Among Norwegian children, we observed in-
creased odds for child overweight/obesity at 5-year
follow-up for each ln-unit increase in maternal serum
PFOS concentration (ORadjusted: 2.96, 95% CI: 1.42–6.15)
and maternal serum PFOA concentration (ORadjusted:
2.90, 95% CI: 1.10–7.63).
To examine potential NMDR relationship between
maternal serum POP concentrations and child over-
weight/obesity outcomes, we used a restricted 3-knot
cubic spline model. Among Swedish participants, we
observed some evidence of a NMDR relationship be-
tween maternal serum PFOS concentration and off-
spring BMI z-scores at 5-year follow-up (p = 0.09 for
non-linearity, Fig. 2). We found also some indications of
a NMDR relationship between maternal serum PCB 153
concentrations and offspring BMI z-scores at 5-year
Table 1 Maternal and child characteristics by country of residence (N = 412)
Maternal characteristics Total (n = 412) Norway (n = 254) Sweden (n = 158) pa
Maternal age (mean years (sd)) 29.0(4.3) 28.8(4.3) 29.2(4.4) 0.364
missing n(%) 3(0.7) 1(0.4) 2(1.3)
Maternal pre-pregnancy BMI (kg/m2) n(%) 0.031
Underweight (BMI < 18.5) 42(10) 31(12) 11(7)
Normal weight (BMI 18.5–25.0) 330(81) 205(81) 125(80)
Overweight (BMI > 25.0) 38(9.3) 17(7) 21(13)
missing n(%) 2(0.4) 1(0.4) 1(0.6)
Maternal education (years) n(%) 0.011
less than 9 67(17) 36(14) 31(20)
9–11 205(50) 142(56) 63(41)
12 or more 135(33) 75(30) 60(39)
missing n(%) 5(1.2) 1(0.4) 4(2.5)
Maternal smoking at conception (number of cigarettes) n(%) < 0.001
0 225(55) 120(47) 105(67)
1–9 42(10) 35(14) 7(4)
10 or more 145(35) 99(39) 46(29)
Parity n(%) 0.245
1 285(69) 181(71) 104(66)
2 127(31) 73(29) 54(34)
Inter-pregnancy interval (years) n(%) 0.187
less than 1.5 102(25) 56(22) 46(29)
1.5–5 225(55) 147(58) 78(49)
5 or more 85(21) 51(20) 34(22)
Previous breastfeeding duration (mean months (sd)) 7.3(5.1) 7.5(5.2) 7.1(5.0) 0.546
missing n(%) 30(7.2) 13(5.1) 17(10.8)
Maternal weight gain up to 17 weeks of gestation (mean kilograms (sd)) 3.2(2.6) 3.1(2.6) 3.3(2.6) 0.601
missing n(%) 30(7.2) 28(11.0) 2(1.3)
Child characteristics at birth
Sex n (%) 0.987
Boys 211(51) 130(51) 81(51)
Girls 201(49) 124(49) 77(49)
Birth weight (mean grams (sd)) 3445(592) 3401 (568) 3515 (625) 0.056
SGA status n(%) 0.908
non-SGA 275(67) 169(67) 106(67)
SGA 137(33) 85(33) 52(33)
Breastfeeding duration of the index child (mean months (sd)) 6.5(3.6) 6.7(3.7) 6.0(3.2) 0.030
missing n(%) 16(3.9) 8(3.1) 8(5.0)
Child characteristics at 5 year follow-up
Exact age at five-year follow-up (mean years (sd) 5.2(0.2) 5.1(0.2) 5.4(0.1) < 0.001
missing n(%) 1(0.2) 0(0) 1(0.6)
Weight 0.708
Underweight (< 5th percentile) 12(3) 7(3) 5(3)
Normal weight (5th–85th percentile.) 346(84) 211(83) 135(87)
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Table 1 Maternal and child characteristics by country of residence (N = 412) (Continued)
Maternal characteristics Total (n = 412) Norway (n = 254) Sweden (n = 158) pa
Overweight (> 85th percentile) 30(7) 21(8) 9(6)
Obese (> 95th percentile) 22(5) 15(6) 7(4)
missing n(%) 2(0.4) 0(0) 2(1.3)
Subscapular skinfolds (mean mm (sd)) 5.6(1.7) 6.0 (1.9) 5.1 (1.2) < 0.001
Triceps skinfolds (mean mm (sd)) 10.0(2.2) 10.4 (2.2) 9.2 (1.9) < 0.001
Subscapular skinfold z-score −0.01(0.8) 0.2(0.7) −0.3(0.8) < 0.001
missing n(%) 29(7.0) 16(6.3) 13(8.2)
Triceps skinfold z-score 0.2(0.7) 0.3(0.6) −0.1(0.7) < 0.001
missing n(%) 25(6.1) 15(5.9) 10(6.3)
BMI-for-sex-and-age z-score 0.1(1.0) 0.2(1.0) 0.1(0.9) 0.499
missing n(%) 2(0.4) 0(0) 2(1.3)
Sd standard deviation, BMI body mass index, SGA small for gestational age
ap-values for comparison between the countries by using independent t-tests for continuous variables and χ2 tests for categorical variables
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ish part of the study.
We tested the generalizability of our results in a
stratum-weighted analysis that accounted for the original
SGA study design that included a higher proportion of
SGA births, a lower prevalence of maternal overweight,
and a higher prevalence of smoking mothers at concep-
tion, compared to the general pregnant population. Our
stratum-weighted analysis did not substantially change
our reported results (Additional file 1: Table S1). Adjust-
ment for maternal fish intake among the Norwegian
women also did not change the estimates (data notTable 2 Wet-weight levels of maternal serum PFASs, and wet-weigh
(n = 412)
Norway (n = 254) Sweden (n =
Median 5th–95th perc. Median
Wet-weight (ng/ml)
PFOA 1.64 0.82–3.54 2.33
PFOS 9.62 3.78–24.6 16.3
PCB 153 0.46 0.26–0.83 0.68
p,p’-DDE 1.30 0.44–4.70 1.30
HCB 0.10 0.05–0.19 0.11
t-NC 0.04 0.02–0.09 0.04
β-HCH 0.12 0.06–0.25 0.13
Lipid-adjusted (ng/g lipids)
PCB 153 79.9 46.8–146 117
p,p’-DDE 211 78.0–844 244
HCB 17.0 10.7–30.1 18.4
t-NC 6.77 3.62–14.5 6.28
β-HCH 21.2 10.7–39.5 25.0
PFAS perfluoroalkyl substance, OC organochlorine, IQR inter-quartile range, SD stand
above LOD, PFOA perfluorooctanoate, PFOS perfluorooctane sulfonate, PCB polychlo
ap-values for comparison between the countries using Mann-Whitney U testshown). Mutual adjustment between maternal serum
PFOS and PCB 153 concentrations, and maternal serum
PFOA and PCB 153 concentrations did not change the
current estimates. However, adding both maternal serum
PFOS and PFOA concentrations into the same model re-
sulted in some attenuation of the estimates probably due
to high correlation between the PFASs (Additional file 1:
Table S2).
Discussion
In this prospective cohort study of 412 mother-child
pairs from Norway and Sweden, we observedt and lipid-adjusted levels of maternal serum OCs, by country
158) pa LOD % > LOD
5th–95th perc.
0.95–4.28 < 0.001 0.03 100
7.17–30.5 < 0.001 0.03 100
0.37–1.10 < 0.001 0.01 100
0.57–4.00 0.174 0.09 100
0.06–0.18 0.522 0.04 100
0.02–0.08 0.020 0.01 100
0.07–0.28 0.007 0.01 99
69.4–179 < 0.001 – –
101–662 0.101 – –
10.3–30.9 0.261 – –
3.25–12.4 0.034 – –
12.6–44.6 < 0.001 – –
ard deviation, LOD limit of detection, %> LOD percentage of serum samples
rinated biphenyl, p,p’-DDE p,p’-dichlorodiphenyldichloroethane, HCB
Table 3 Adjusted associations between ln-units of maternal serum POPs and BMI-for-age-and-sex z-scores, subscapular and triceps
skinfold z-scores (βs and 95% CIs) and child obesity/overweight (OR and 95% CI) at 5 years of age, overall and by country
Maternal serum
POPs
Child outcomes at five-year follow-up (n = 412)
All participants (n = 412)a Norway (n = 254)b Sweden (n = 158)b
BMI-for-age-and-sex z-score
β (95% CI) pint c
PFOS 0.18 (0.01, 0.35) 0.30 (0.08, 0.51) −0.11 (−0.41, 0.19) 0.039
PFOA 0.18 (−0.03, 0.39) 0.32 (0.05, 0.60) −0.07 (−0.41, 0.27) 0.129
PCB 153 0.30 (−0.03, 0.63) 0.45 (0.03, 0.87) 0.11 (−0.43, 0.65) 0.509
p,p’-DDE 0.03 (−0.12, 0.18) 0.04 (−0.15, 0.23) 0.02 (−0.24, 0.29) 0.932
HCB 0.16 (−0.13, 0.45) 0.36 (−0.03, 0.75) −0.11 (−0.56, 0.34) 0.154
b-HCH 0.17 (−0.08, 0.43) 0.17 (−0.16, 0.51) 0.14 (−0.26, 0.55) 0.823
t-NC 0.11 (−0.13, 0.35) 0.23 (−0.07, 0.54) −0.12 (−0.53, 0.29) 0.380
Triceps skinfold z-score
β (95% CI)
PFOS 0.15 (0.02, 0.27) 0.20 (0.06, 0.35) −0.02 (−0.27, 0.22) 0.255
PFOA 0.14 (−0.02, 0.29) 0.24 (0.05, 0.42) −0.05 (−0.33, 0.23) 0.223
PCB 153 −0.08 (−0.31, 0.16) 0.02 (−0.27, 0.31) −0.33 (−0.77, 0.11) 0.638
p,p’-DDE −0.04 (−0.15, 0.07) 0.004 (−0.13, 0.14) −0.12 (−0.33, 0.10) 0.905
HCB 0.02 (−0.20, 0.24) 0.07 (−0.20, 0.35) −0.11 (−0.48, 0.26) 0.914
b-HCH 0.10 (−0.08, 0.29) 0.10 (−0.13, 0.32) 0.07 (−0.27, 0.41) 0.271
t-NC −0.03 (−0.20, 0.15) 0.05 (−0.16, 0.25) −0.32 (−0.64, 0.02) 0.497
Subscapular skinfold z-score
β (95% CI)
PFOS 0.07 (−0.07, 0.20) 0.12 (−0.04, 0.29) −0.07 (−0.35, 0.22) 0.304
PFOA −0.03 (−0.20, 0.15) 0.04 (−0.18, 0.25) −0.11 (−0.42, 0.21) 0.470
PCB 153 −0.05 (−0.32, 0.23) 0.07 (−0.26, 0.41) −0.30 (−0.80, 0.20) 0.432
p,p’-DDE −0.07 (−0.19, 0.06) −0.04 (−0.18, 0.11) −0.10 (−0.34, 0.14) 0.917
HCB −0.08 (−0.33, 0.17) −0.05 (−0.36, 0.27) −0.21 (−0.62, 0.20) 0.977
b-HCH 0.14 (−0.07, 0.35) 0.10 (−0.16, 0.36) 0.17 (−0.21, 0.55) 0.528
t-NC −0.13 (−0.34, 0.07) −0.08 (−0.32, 0.16) −0.34 (−0.71, 0.04) 0.698
Overweight (≥ 85th percentile)
OR (95% CI)
N overweight/total 52/412 (13%) 36/254 (14%) 16/158 (10%)
PFOS 2.04 (1.11–3.74) 2.96 (1.42–6.15) 0.71 (0.21–2.45) 0.098
PFOA 1.61 (0.75–3.46) 2.90 (1.10–7.63) 0.50 (0.12–2.06) 0.119
PCB 153 1.37 (0.42–4.49) 2.13 (0.49–9.26) 0.60 (0.06–6.03) 0.944
p,p’-DDE 0.88 (0.52–1.49) 1.11 (0.58–2.14) 0.61 (0.20–1.83) 0.792
HCB 1.51 (0.55–4.13) 2.30 (0.62–8.50) 0.60 (0.10–3.62) 0.806
b-HCH 2.14 (0.86–5.32) 2.17 (0.67–6.99) 1.56 (0.29–8.39) 0.529
t-NC 1.44 (0.63–3.31) 1.69 (0.62–4.62) 0.78 (0.15–1.19) 0.745
aAdjusted for maternal age, education, smoking at conception, pre-pregnancy BMI, weight gain at 17 weeks, interpregnancy interval, previous breastfeeding
duration and country of residence
bAdjusted for maternal age, education, smoking at conception, pre-pregnancy BMI, weight gain at 17 weeks, interpregnancy interval and previous
breastfeeding duration
cp-value for interaction between exposure and country
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All participants (n=412) 
Sweden (n=158)      
Norway (n=254)
Fig. 2 Adjusted restricted cubic spline with 3 knots for maternal serum
PFOS concentrations and offspring BMI-for-age-and-sex z-score at 5-year
follow-up, overall and stratified by country. All models are adjusted
adjusted for maternal age, pre-pregnancy body mass index, education,
smoking status during pregnancy, inter-pregnancy interval, previous
breastfeeding duration and maternal weight gain up to 17 weeks of
gestation. The overall model is additionally adjusted for country of origin.
The solid line represents the mean BMI z-score and the shaded area
represents the 95% confidence interval
All participants (n=412) 
Sweden (n=158)   
Norway (n=254)
Fig. 3 Adjusted restricted cubic spline with 3 knots for maternal serum
PCB 153 concentrations and offspring BMI-for-age-and-sex z-score at
5–year follow-up, overall and stratified by country. All models are
adjusted for maternal age, pre-pregnancy body mass index, education,
smoking status during pregnancy, inter-pregnancy interval, previous
breastfeeding duration and maternal weight gain up to 17 weeks of
gestation. The overall model are additionally adjusted for country of
origin. The solid line represents the mean BMI z-score and the shaded
area represents the 95% confidence interval
Lauritzen et al. Environmental Health  (2018) 17:9 Page 9 of 12positive associations between maternal serum PFAS
concentrations and child BMI and triceps skinfold
z-scores, as well as child overweight/obesity at 5-year
follow-up, particularly among Norwegian women. We
also found evidence of NMDR relationships between
maternal serum PFOS and PCB 153 concentrations
and offspring BMI z-scores among Swedish
participants.Evidence of prenatal exposure to PFASs and child post-
natal growth and obesity is limited and the results have
been inconsistent. A Danish study with maternal plasma
PFAS concentrations like ours (median PFOS: 10.8 ng/ml,
PFOA: 1.3 ng/ml), found positive associations between
PFOS and PFOA concentrations and waist-to-height ratio
in 5–9-year-old girls and boys [12]. However, studies with
higher maternal PFAS concentrations have been more
Lauritzen et al. Environmental Health  (2018) 17:9 Page 10 of 12inconsistent. Three studies with higher maternal plasma
PFAS concentrations than our study (median PFOS: 19.6–
24.8 ng/ml, PFOA: 3.7–5.6 ng/ml) showed positive associ-
ations between increasing PFAS concentrations and mea-
sures of child obesity (10, 11, 14). However, another
Danish study with even higher maternal plasma PFAS
concentrations (median PFOS: 33 ng/ml, PFOA: 5.2 ng/
ml) found no or inverse associations between increasing
PFAS concentrations and BMI or waist circumference
among 7-year-old children [16]. Another study with
higher maternal serum PFOA concentrations (median:
5.3 ng/ml) than ours, observed a NMDR relationship be-
tween increasing PFOA concentrations and BMI at 8 years
of age [13]. From this, we may speculate that low maternal
serum or plasma PFAS concentrations show positive asso-
ciations with child obesity, while higher maternal serum
or plasma PFAS concentrations show positive, negative, or
NMDR relationships with child obesity, depending on the
range of PFAS concentrations measured in the study
population. This is in agreement with a recent review sug-
gesting that NMRD relationships may be observed with
EDCs, and that the effects of high doses EDCs cannot pre-
dict the effects of EDCs at lower doses [40]. Possible
mechanisms for these NMDR relationships include cyto-
toxicity, cell- and tissue-specific receptors and cofactors,
receptor selectivity, receptor down-regulation and
desensitization, receptor competition and endocrine nega-
tive feedback loops [40]. This is consistent with our differ-
ent findings between Norwegian participants (with lower
maternal serum PFAS concentrations) compared to Swed-
ish participants (with higher maternal serum PFAS con-
centrations). These results support a potential cytotoxic
effect of high levels of PFASs in utero that can result in
growth restricted offspring, which is consistent with the
positive associations we found between maternal PFAS
concentrations and SGA birth among the Swedish partici-
pants in our study [35]. Consequently, this effect may
distort the association between maternal serum PFAS
concentrations and child obesity at 5-year follow-up.
However, a possible obesogenic effect may appear later in
the latter development of growth restricted offspring.
NMDR relationships have also been proposed for associa-
tions between maternal serum PCB concentrations and
offspring growth and obesity [41]. A recent review catego-
rized n = 9 prospective cohort studies according to the
level of maternal serum PCB concentrations whereby the
authors suggested that low maternal serum PCB concen-
tration (PCBs < 1000 ng/g lipids) was associated with in-
creased offspring BMI or body weight, while high maternal
serum PCB concentration (PCBs > 4000 ng/g lipids) was
associated with decreased offspring BMI or body weight
[41]. Taken together with our finding of a NMDR relation-
ship between maternal serum PCB 153 concentrations and
child overweight/obesity at 5-year follow-up amongSwedish only participants, there is some indication that
low maternal serum exposure concentrations may lead to
offspring obesity, while higher concentrations of PCBs
may exert cytotoxic effects on the fetus, resulting in poor
fetal growth and development. However, it is difficult to
compare concentration ranges in our study with results
from this review, as the review considered total maternal
serum PCB concentrations [41].
The current study has several strengths including the
relatively substantial number of mother-child pairs (n =
412). We measured maternal serum PFAS and OC con-
centrations early in pregnancy, and evaluated mothers
and children throughout pregnancy, infancy and into
early childhood using detailed clinically based outcome
assessments. The use of standardized anthropometric
measurements may reduce possible misclassification and
enhance the statistical precision of our estimates. To our
knowledge, only one previous study has assessed the
relationship between maternal serum prenatal PFAS
concentrations and offspring triceps and subscapular
skinfold thickness [11]. Studies that measure only BMI
are limited by the fact that BMI is not a direct measure
of fat distribution. As such, children with the same BMI
may differ considerably in total amount of body fat [42].
Skinfold thickness, as applied in our study, is used as a
measure of subcutaneous fat, which has been reported
to be highly correlated with total amount body fat [19,
43]. We were also able to examine and/or adjust for sev-
eral important prenatal and postnatal factors. Our study
is one of few studies to investigate a variety of maternal
serum PFAS and OC exposures.
The current study also has some limitations. Although
we included a range of covariates in multivariate models,
we cannot rule out possible residual confounding related
to socio-economic and lifestyle differences between
high-consumers of seafood in Norway compared to
Sweden. However, adjustment for maternal fish intake
among Norwegian participants did not change the
results. The contamination pattern and POP concentra-
tions in seafood from the Baltic Sea on the East Coast of
Sweden is different compared to the seafood consumed
in Norway [22]. Thus, the possible nutrient/contaminant
interaction might be different in the two countries. We
acknowledge that SGA births were overrepresented in
our study cohort compared to the general pregnant
population, which may introduce selection bias or prob-
lems with generalizability. Also, the high prevalence of
maternal smoking and the low prevalence of maternal
overweight in our study compared to recent pregnant
populations [44], might distort the estimates. However,
results from stratum-weighted analyses showed no
change in reported results. Still, results from this study
may not be generalizable to primiparous women, as
only parous women were eligible for study inclusion.
Lauritzen et al. Environmental Health  (2018) 17:9 Page 11 of 12Although skinfold measurements in children are more
correlated with body fat mass, they are prone to intra-
and inter-observer errors [32]. We had no information
about the inter-observer reliability, but we assume that
measurement precision was un-correlated with mater-
nal serum EDC concentrations. Persistent and bio-
accumulative chemicals with comparable properties are
highly correlated. Therefore, our point estimates may
be subject to residual confounding due to some
unmeasured chemicals (e.g. lead) in our analyses.
Finally, we must interpret our country-specific results
with caution due to small numbers.
Conclusion
Our study shows that increasing maternal serum PFAS
concentrations were associated with increasing child BMI
and triceps skinfold z-scores, in addition to child over-
weight/obesity at 5-year follow-up, but this association
may differ geographically and by maternal serum PFAS
concentration. Our results also highlight the importance
of assessing NMDR relationships for POP exposures.
More prospective studies on the association between
maternal serum POP concentrations and overweight/
obesity among older children and adults are needed.
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